Home/Filings/4/0001209191-09-003784
4//SEC Filing

Tecce Frederick C. 4

Accession 0001209191-09-003784

CIK 0001309442other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 3:05 PM ET

Size

11.1 KB

Accession

0001209191-09-003784

Insider Transaction Report

Form 4
Period: 2009-01-15
Tecce Frederick C.
Director10% Owner
Transactions
  • Purchase

    Warrant to Purchase Series A Convertible Preferred Stock

    2009-01-15$4000000.00/sh+1,000,000$4,000,000,000,0001,000,000 total(indirect: See Footnote)
    Exercise: $4.00Exp: 2014-01-14Series A Convertible Preferred Stock (1,000,000 underlying)
  • Purchase

    Series A Convertible Preferred Stock

    2009-01-15$4.00/sh+1,000,000$4,000,0001,000,000 total(indirect: See Footnote)
    Exercise: $0.20Common Stock (20,000,000 underlying)
Holdings
  • Common Stock, par value $0.001 per share

    100,000
  • Common Stock, par value $0.001 per share

    (indirect: See Footnote)
    6,350,877
Footnotes (3)
  • [F1]Represents securities owned by The Co-Investment Fund II, L.P. (the "Fund"), the designee of Cross Atlantic Capital Partners, Inc., of which Mr. Tecce is the managing director. The Reporting Person disclaims beneficial ownership of the shares held by the Fund except to the extent of his pecuniary interest therein.
  • [F2]The Series A Convertible Preferred Stock is convertible, at the option of the holder, into shares of common stock at any time after the date on which either (a) an amendment to the Company's certificate of incorporation increasing the number of the Company's authorized shares to 200,000,000 shall have become effective and (b) the full number of shares of common stock issuable upon conversion or exercise of the Series A Convertible Preferred Stock and warrants have become available and reserved for issuance upon conversion or exercise of such securities. There is no expiration date.
  • [F3]The warrants automatically become exercisable upon the earlier to occur of (a) stockholder approval of a proposal to increase the authorized shares of common stock of the Registrant (at which point the warrants become automatically exercisable for shares of common stock of the Registrant on a 20 for 1 basis) or (b) March 30, 2009 (or April 14, 2009, in the event of SEC review of the Registrant's proxy statement containing the proposal to increase the authorized shares of common stock of the Registrant). In the event the stockholders do not approve a proposal to increase the authorized shares of common stock of the Registrant, and from thereafter until such point when the stockholders approve such increase, the warrants remain exercisable for shares of preferred stock.

Issuer

HEALTH BENEFITS DIRECT CORP

CIK 0001309442

Entity typeother

Related Parties

1
  • filerCIK 0001408321

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 3:05 PM ET
Size
11.1 KB